Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FitFlow vs Genesis Health

By GLP-1 ScorecardUpdated

FitFlow
Site position #172

Higher grade

Genesis Health
Site position #331

Lower grade

Score comparison

FitFlow has the higher recorded score — 67.8/100 to 61.4/100.

FitFlow grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FitFlow (FitFlow Health) is a 100% online compounded telehealth platform for GLP-1 weight loss - compounded semaglutide (=Wegovy) and tirzepatide (=Mounjaro).

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueFitFlow +6
58
52
Dose & formulationEven
77
77
Clinical oversightFitFlow +30
85
55
Labs & monitoringGenesis Health +8
55
63
FulfillmentFitFlow +8
81
73
Contract termsGenesis Health +10
37
47
FitFlow · top barGenesis Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricFitFlowGenesis Health
WeighScore67.8/10061.4/100
GradeCC
Site position#172#331
Semaglutide$175/mo (compounded)$175/mo (starting dose, compounded)
Tirzepatide$235/mo (compounded)$235/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
FitFlow

Site position #172 · C

Strengths

  • Compounded semaglutide (=Wegovy) and tirzepatide (=Mounjaro); month-to-month from $175/$235, or as low as $99/$125 on annual prepay
  • 100% online 4-step process; board-certified provider review in 24-48 hours, with unlimited messaging and dose adjustments
  • Free nationwide shipping (discreet, 5-7 days) from US-licensed compounding pharmacies
  • FSA/HSA eligible with financing (Affirm, Klarna, Afterpay); month-to-month or prepay plans, cancel anytime
  • Transparent 'no hidden fees' pricing; 6,000+ members; same-platform add-ons (NAD+, sermorelin, MIC+B12, glutathione, hair, sexual health)

What to consider

  • Headline '$99/$125 a month' requires a full year prepaid upfront ($1,188 / $1,500); true month-to-month is $175 / $235
  • Compounded medications are not FDA-approved - not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • The compounding pharmacy partner is not named ('US-licensed / FDA-regulated pharmacies' only)
  • State-availability list is not published (free nationwide shipping advertised, but no explicit state list)
  • No LegitScript certification displayed
Genesis Health

Site position #331 · C

FDAWarning letter issued to Genesis Health International Inc. dba Genesis in February 2026. See the FDA warning-letter database.

Strengths

  • Annual plan as low as $99/mo for semaglutide or $125/mo for tirzepatide
  • Offers both compounded and brand-name GLP-1s (Wegovy, Ozempic, Zepbound) in one platform
  • Includes health coaching, active community, and free expedited shipping on every plan
  • LegitScript certified; medications sourced from audited, licensed US compounding pharmacies
  • Same-day provider visits, personalized dosing, and 24/7 care team messaging

What to consider

  • States served not publicly listed; telehealth coverage unconfirmed for all states
  • Monthly starting price ($175 sema / $235 tirz) is mid-market without annual commitment
  • Labs not disclosed or included in any published plan tier
  • Brand-name GLP-1 pricing not published; insurance or coupon required
  • FDA issued Genesis Health International Inc. dba Genesis a warning letter in February 2026; the letter is public in FDA's warning-letter database

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard